Answers are grounded in this paper and cite their sources.
Assesses astegolimab outcomes in COPD, highlighting its efficacy and safety implications.
Dave Singh, Mark Dransfield; Astegolimab in COPD: success or failure?, American Journal of Respiratory and Critical Care Medicine, , aamag343, https://doi.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: